Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

 Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines showed strong immune responses in some patients tested in a late-stage study, the company said on Wednesday.

https://www.marketscreener.com/quote/stock/NOVAVAX-INC-58256108/news/Novavax-s-COVID-flu-combo-and-standalone-flu-shots-improve-immunity-in-late-stage-study-50213371/